XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Capitalization
 6 Months Ended
Mar. 31, 2023
Capitalization, Long-Term Debt and Equity [Abstract]  
Capitalization Capitalization
Summary of Changes in Common Stock Equity
 Common StockPaid In
Capital		Earnings
Reinvested
in the
Business		Accumulated
Other
Comprehensive
Income (Loss)
SharesAmount
 (Thousands, except per share amounts)
Balance at January 1, 202391,787 $91,787 $1,025,639 $1,713,176 $(293,746)
Net Income Available for Common Stock140,880 
Dividends Declared on Common Stock ($0.475 Per Share)(43,602)
Other Comprehensive Income, Net of Tax238,882 
Share-Based Payment Expense (1)
5,200 
Common Stock Issued Under Stock and Benefit Plans8 8 502 
Balance at March 31, 202391,795 $91,795 $1,031,341 $1,810,454 $(54,864)
Balance at October 1, 202291,478 $91,478 $1,027,066 $1,587,085 $(625,733)
Net Income Available for Common Stock310,570 
Dividends Declared on Common Stock ($0.95 Per Share)(87,201)
Other Comprehensive Income, Net of Tax570,869 
Share-Based Payment Expense (1)
10,318 
Common Stock Issued (Repurchased) Under Stock and Benefit Plans317 317 (6,043)
Balance at March 31, 202391,795 $91,795 $1,031,341 $1,810,454 $(54,864)
Balance at January 1, 202291,437 $91,437 $1,013,821 $1,281,963 $(277,026)
Net Income Available for Common Stock167,328 
Dividends Declared on Common Stock ($0.455 Per Share)(41,608)
Other Comprehensive Loss, Net of Tax(377,228)
Share-Based Payment Expense (1)
4,692 
Common Stock Issued Under Stock and Benefit Plans12 12 271 
Balance at March 31, 202291,449 $91,449 $1,018,784 $1,407,683 $(654,254)
Balance at October 1, 202191,182 $91,182 $1,017,446 $1,191,175 $(513,597)
Net Income Available for Common Stock299,720 
Dividends Declared on Common Stock ($0.91 Per Share)(83,212)
Other Comprehensive Loss, Net of Tax(140,657)
Share-Based Payment Expense (1)
9,732 
Common Stock Issued (Repurchased) Under Stock and Benefit Plans
267 267 (8,394)
Balance at March 31, 202291,449 $91,449 $1,018,784 $1,407,683 $(654,254)

(1)Paid in Capital includes compensation costs associated with performance shares and/or restricted stock awards. The expense is included within Net Income Available For Common Stock, net of tax benefits.
 
Common Stock.  During the six months ended March 31, 2023, the Company issued 12,055 original issue shares of common stock as a result of SARs exercises, 113,531 original issue shares of common stock for restricted stock units that vested and 278,687 original issue shares of common stock for performance shares that vested.  The Company also issued 14,680 original issue shares of common stock to the non-employee directors of the Company who receive compensation under the Company’s 2009 Non-Employee Director Equity Compensation Plan, including the reinvestment of dividends for certain non-employee directors who elected to defer their shares pursuant to the dividend reinvestment feature of the Company's Deferred Compensation Plan for Directors and Officers (the "DCP") during the six months ended March 31, 2023.  In addition, the Company issued 824 original issue shares of common stock to officers of the Company who elected to defer their shares pursuant to the dividend reinvestment feature of the Company's DCP Plan during the six months ended March 31, 2023.
Holders of stock-based compensation awards will often tender shares of common stock to the Company for payment of applicable withholding taxes.  During the six months ended March 31, 2023, 102,761 shares of common stock were tendered to the Company for such purposes.  The Company considers all shares tendered as cancelled shares restored to the status of authorized but unissued shares, in accordance with New Jersey law.

Short-Term Borrowings. On June 30, 2022, the Company entered into a new 364-Day Credit Agreement (the "364-Day Credit Agreement") with a syndicate of five banks, all of which are also lenders under the Credit Agreement. The 364-Day Credit Agreement provides an additional $250.0 million unsecured committed delayed draw term loan credit facility with a maturity date of June 29, 2023. The Company elected to draw $250.0 million under the facility on October 27, 2022. The Company used the proceeds for general corporate purposes, which included using $150.0 million for the November 2022 redemption of a portion of the Company's outstanding long-term debt with a maturity date in March 2023.
 
Current Portion of Long-Term Debt. None of the Company's long-term debt as of March 31, 2023 had a maturity date within the following twelve-month period. The Current Portion of Long-Term Debt at September 30, 2022 consisted of $500.0 million of 3.75% notes and $49.0 million of 7.395% notes. The Company redeemed $150.0 million of the 3.75% notes on November 25, 2022 using a portion of the proceeds from short-term borrowings, as discussed above. In March 2023, the Company redeemed the remaining $350.0 million of the 3.75% notes as well as the $49.0 million of 7.395% notes.